Correlation Between Neurones and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurones and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurones and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurones and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Neurones and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurones with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurones and Sartorius Stedim.

Diversification Opportunities for Neurones and Sartorius Stedim

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Neurones and Sartorius is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Neurones and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Neurones is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurones are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Neurones i.e., Neurones and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Neurones and Sartorius Stedim

Assuming the 90 days trading horizon Neurones is expected to generate 0.44 times more return on investment than Sartorius Stedim. However, Neurones is 2.26 times less risky than Sartorius Stedim. It trades about -0.15 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.12 per unit of risk. If you would invest  4,740  in Neurones on August 28, 2024 and sell it today you would lose (165.00) from holding Neurones or give up 3.48% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neurones  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Neurones 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Neurones are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Neurones is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Neurones and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurones and Sartorius Stedim

The main advantage of trading using opposite Neurones and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurones position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Neurones and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments